Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05782868 · ClinicalTrials.gov registry record · NA
Expressive Writing Intervention Study
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT05782868 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 117 participants.
The verdict
NCT05782868, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
This study aims to test to what extent an expressive writing intervention may reduce internalized anti-TNB (trans and nonbinary) stigma and promote well-being over time. Trans and/or nonbinary people may take part in this study, and can expect to participate for 3 months.
Interventions
- OTHER Expressive writing in response to vignette
- OTHER Expressive writing about events of the day
- OTHER Letter of Gratitude
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05782868
The ClinicalTrials.gov registry entry for NCT05782868 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Expressive writing in response to vignette is the first listed.
NCT05782868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05782868 about?
NCT05782868 is a clinical study titled "Expressive Writing Intervention Study". This study aims to test to what extent an expressive writing intervention may reduce internalized anti-TNB (trans and nonbinary) stigma and promote well-being over time. Trans and/or nonbinary people may take part in this study, and can expect to participate for 3 months.
What is the current status of trial NCT05782868?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2023-09-08. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT05782868?
The interventions under investigation include: Expressive writing in response to vignette (OTHER), Expressive writing about events of the day (OTHER), Letter of Gratitude (OTHER).
Who is sponsoring clinical trial NCT05782868?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.